The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 10, 2020

Filed:

Jan. 08, 2018
Applicant:

Alkermes Pharma Ireland Limited, Dublin, IE;

Inventors:

Tarek A. Zeidan, Lexington, MA (US);

Laura Cook Blumberg, Lincoln, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); A61K 31/496 (2006.01); A61P 25/18 (2006.01); C07D 215/227 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 263/58 (2006.01); C07D 277/34 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 215/227 (2013.01); C07D 263/58 (2013.01); C07D 277/34 (2013.01); C07D 401/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 519/00 (2013.01);
Abstract

The present invention accomplishes this by having multiple molecules of parent drugs attached to carrier moieties and by extending the period during which the parent drug is released and absorbed after administration to the patient and providing a longer duration of action per dose than the parent drug itself. Prodrug conjugates are suitable for sustained delivery of heteroaryl, lactam-amide-, imide-, sulfonamide-, carbamate-, urea-, benzamide-, acylaniline-, cyclic amide- and tertiary amine-containing parent drugs that are substituted at the amide nitrogen or oxygen atom with labile aldehyde-linked prodrug moieties. The carrier groups of the prodrugs can be hydrophobic to reduce the polarity and solubility of the parent drug under physiological conditions.


Find Patent Forward Citations

Loading…